Ruskoaho H, Vakkuri O, Arjamaa O, Vuolteenaho O, Leppäluoto J
Department of Pharmacology, University of Oulu, Finland.
Circ Res. 1989 Mar;64(3):482-92. doi: 10.1161/01.res.64.3.482.
Atrial wall stretching is a known stimulus for atrial natriuretic peptide (ANP) secretion. The effects of the stimulation of autonomic nervous system, hemodynamic factors, and humoral factors (epinephrine, angiotensin, vasopressin, and brain extracts) on the release of ANP under basal conditions and during increased atrial pressure produced by acute volume loading in pithed rats were examined. In conscious rats, acute volume expansion by 0.9% of saline (4 ml) increased the plasma immunoreactive ANP (IR-ANP) concentrations by a factor of 4 (140 +/- 30 pg/ml vs. 521 +/- 140 pg/ml, p less than 0.001, n = 8), whereas volume-induced ANP release was blocked in pithed rats (75 +/- 9 pg/ml vs. 99 +/- 13 pg/ml, NS, n = 7). The ANP versus right atrial pressure curve shifted to the right, indicating that much smaller amounts of IR-ANP were released in pithed than in conscious rats for each given increase in right atrial pressure. Electrical vagal and sympathetic nerve stimulation or changes in heart rate had no effect on plasma IR-ANP concentrations and failed to restore the volume-load-induced release of ANP in pithed rats. When extracts of anterior pituitary lobe, brain cortex, or hypothalamus were infused, no effect on volume-expansion-induced plasma IR-ANP levels was seen. In contrast, acute volume expansion caused a fourfold increase in levels of circulating IR-ANP in pithed rats that received posterior pituitary extracts, and the ANP versus right atrial pressure curve shifted markedly to the left. Infusion of a V1 antagonist blocked the volume-expansion-induced ANP release produced by the posterior pituitary extract. When [Arg8]-vasopressin (0.025 or 0.05 micrograms/kg/min) was infused to pithed rats, mean arterial pressure increased but basal plasma IR-ANP did not change significantly. However, acute volume expansion in the presence of vasopressin infusion (0.05 micrograms/kg/min) increased the amount of circulating IR-ANP by a factor of 4 (113 +/- 14 pg/ml vs. 414 +/- 43 pg/ml, p less than 0.001, n = 8). Thus, for a given increase in right atrial pressure, a similar amount of IR-ANP was released in the pithed rat during the vasopressin infusion as in the normal conscious animal. V1 antagonist blocked the increase in mean aterial pressure as well as the increase of plasma IR-ANP produced by [Arg8]-vasopressin. In addition, volume expansion during intravenous epinephrine (1.75 micrograms/kg/min) and angiotensin (1.0 micrograms/kg/min) doubled plasma IR-ANP levels.(ABSTRACT TRUNCATED AT 400 WORDS)
心房壁拉伸是已知的心房利钠肽(ANP)分泌刺激因素。研究了在基础条件下以及在急性容量负荷使去大脑大鼠心房压力升高期间,自主神经系统刺激、血流动力学因素和体液因素(肾上腺素、血管紧张素、血管加压素和脑提取物)对ANP释放的影响。在清醒大鼠中,0.9%生理盐水(4毫升)急性容量扩张使血浆免疫反应性ANP(IR-ANP)浓度增加了4倍(140±30皮克/毫升对521±140皮克/毫升,p<0.001,n=8),而容量诱导的ANP释放在去大脑大鼠中被阻断(75±9皮克/毫升对99±13皮克/毫升,无显著性差异,n=7)。ANP与右心房压力曲线向右移动,表明对于每次给定的右心房压力升高,去大脑大鼠释放的IR-ANP量比清醒大鼠少得多。迷走神经和交感神经电刺激或心率变化对血浆IR-ANP浓度无影响,也不能恢复去大脑大鼠容量负荷诱导的ANP释放。当注入垂体前叶、大脑皮层或下丘脑提取物时,未观察到对容量扩张诱导的血浆IR-ANP水平有影响。相反,急性容量扩张使接受垂体后叶提取物的去大脑大鼠循环IR-ANP水平增加了4倍,且ANP与右心房压力曲线明显向左移动。注入V1拮抗剂可阻断垂体后叶提取物产生的容量扩张诱导的ANP释放。当向去大脑大鼠注入[精氨酸8]-血管加压素(0.025或0.05微克/千克/分钟)时,平均动脉压升高,但基础血浆IR-ANP无明显变化。然而,在注入血管加压素(0.05微克/千克/分钟)的情况下急性容量扩张使循环IR-ANP量增加了4倍(113±14皮克/毫升对414±43皮克/毫升,p<0.001,n=8)。因此,对于给定的右心房压力升高,在注入血管加压素期间去大脑大鼠释放的IR-ANP量与正常清醒动物相似。V1拮抗剂可阻断[精氨酸8]-血管加压素引起的平均动脉压升高以及血浆IR-ANP升高。此外,静脉注射肾上腺素(1.75微克/千克/分钟)和血管紧张素(1.0微克/千克/分钟)期间的容量扩张使血浆IR-ANP水平加倍。(摘要截断于400字)